BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 3004705)

  • 1. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
    De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
    Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of type alpha transforming growth factor receptors by a phorbol ester tumor promoter.
    Davis R; Like B; Massagué J
    J Cell Biochem; 1985; 27(1):23-30. PubMed ID: 2984222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
    Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
    Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
    J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
    Rizzino A; Ruff E; Rizzino H
    Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of retinoids on the anchorage-independent growth of normal rat kidney fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate or sarcoma growth factor.
    Jetten AM
    Cancer Res; 1983 Jan; 43(1):68-72. PubMed ID: 6571709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
    Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
    Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
    van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
    J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
    Rijksen G; Völler MC; Van Zoelen EJ
    J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of epidermal growth factor and insulin on the specific binding of transforming growth factor beta by NRK-49F and A-459 cell lines].
    Sushel'nitskiĭ SI; Stoĭka RS; Kusen' SI
    Tsitologiia; 1991; 33(3):80-7. PubMed ID: 1666203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells.
    Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1984 Apr; 44(4):1635-41. PubMed ID: 6322983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF.
    Lahaye DH; Camps MG; Erp PE; Peters PH; Zoelen EJ
    J Cell Physiol; 1998 Jan; 174(1):9-17. PubMed ID: 9397151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
    Jullien P; Berg TM; de Lannoy C; Lawrence DA
    J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of anchorage-independent cell growth by endothelin in NRK 49F cells.
    Kusuhara M; Yamaguchi K; Kuranami M; Suzaki A; Ishikawa S; Moon H; Adachi I; Hori S; Handa S
    Cancer Res; 1992 Jun; 52(11):3011-4. PubMed ID: 1317255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.